BACTOCIN 6CPS VAG MOLLI 3G

BACTOCIN CHAPTER MOLLS

active ingredients

• Each vaginal capsule contains: Active ingredient: Lactobacillus plantarum P 17630⁸ UFC. For the list of excipients see paragraph 6.1

Excellent

• Each vaginal soft capsule contains: Medium chain triglycerides - Silice (Aerosil 300) - Gelatin - Glicerol - Dimethylpolisyloxane - Titanium dioxide (E 171).

Therapeutic indications

BACTOCIN vaginal soft capsules find indication in the "vaginiti and vulvo-vaginiti" in general, as the lactobacilli in them present, implanting and multiplying on the vaginal mucosa, as well as bringing to balance the autochthonous bacterial flora, antagonize, indirectly by competition, colonization by pathogenic germs. BACTOCIN is therefore used in the topical therapy of vaginal infections supported by pathogenic germs. In particular, in vaginitis associated with ovarian insufficiency, hypofollicolinic leucorrea, infant vaginiti, senile vaginiti, vulvarious itching, vaginal dystrophìa. BACTOCIN is also used as an adjuvant in chemotherapy and antibiotic treatment in vaginitis from Trichomonas.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.

Population

Population: A vaginal capsule a day. Method of administration: Introduce a capsule deeply into the vagina, in supine position, the evening before bedtime.

Conservation

Store at temperature between 2°C and 8°C

Warnings

BACTOCIN: does not replace antibiotic therapy or chemotherapy, but represents a useful complement by restoring, especially at the end of the specific treatment, the physiological conditions of the vaginal environment.

Interactions

Not known.

Effects

Undesirable effects related to product use have not been reported. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversa.

Overdosing

No known effects to be attributed to overdose.

II Lactobacillus plantarum is habitual non pathogen host of the vagina, therefore BACTOCIN can be used in pregnancy and/or during breastfeeding.

Source: Farmadati